• Something wrong with this record ?

Evaluation of health and quality of life in apheresis patients - data from the WAA register

J. Goto, E. Newman, V. Witt, D. Deeren, M. Blaha, M. Lanska, Z. Gasova, Z. Bhuiyan-Ludvikova, R. Hrdlickova, W. Ramlow, H. Prophet, G. Liumbruno, A. Griskevicius, J. Audzijoniene, H. Vrielink, A. Aandahl, SO. Sanchez, V. Strineholm, G. Berlin, M....

. 2019 ; 58 (5) : 641-644. [pub] 20190905

Language English Country Great Britain

Document type Clinical Trial, Journal Article, Multicenter Study

Persistent link   https://www.medvik.cz/link/bmc20023662

OBJECTIVE: The World Apheresis Association (WAA) register contains data from more than 89 000 apheresis procedures in more than 12,000 patients. The aim of this study was to evaluate functional health and quality of life (QoL) in patients during apheresis treatment. MATERIAL AND METHODS: Estimates of health condition (HC) were made in 40,445 and of QoL in 22112 apheresis procedures. This study focused on a 10-step graded evaluation of HC (scale from: 'bedridden, unable to eat' to a level of 'athletic competition') and self-assessment of QoL (scale from: worst ever '0' to best ever '10'). Data were compared in relation to various apheresis procedures and if the patient underwent the first or subsequent apheresis procedure. RESULTS: Of the patients treated with plasma exchange (PEX) with centrifugation technique (n = 15787) 10% were 'bedridden, unable to come out of bed' while for patients treated with plasma filtration technique (n = 1018) the percentage was 27%. During the first procedure these figures were 16% and 30%, respectively. Self-estimates of QoL were graded 'zero' or '1' in 1.6% of patients during the first apheresis procedure; At the first contact patients undergoing PEX graded like this in 4.3%. CONCLUSION: Many of the patients undergoing apheresis treatment have poor HC and QoL at the start of therapy. Of all therapeutic apheresis procedures patients undergoing PEX had the lowest score of QoL.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20023662
003      
CZ-PrNML
005      
20201214130746.0
007      
ta
008      
201125s2019 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.transci.2019.08.024 $2 doi
035    __
$a (PubMed)31519525
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Goto, J $u Umeå, Sweden; Yamanashi, Japan.
245    10
$a Evaluation of health and quality of life in apheresis patients - data from the WAA register / $c J. Goto, E. Newman, V. Witt, D. Deeren, M. Blaha, M. Lanska, Z. Gasova, Z. Bhuiyan-Ludvikova, R. Hrdlickova, W. Ramlow, H. Prophet, G. Liumbruno, A. Griskevicius, J. Audzijoniene, H. Vrielink, A. Aandahl, SO. Sanchez, V. Strineholm, G. Berlin, M. Mörtzell-Henriksson, BG. Stegmayr, T. Eich, O. Ilhan,
520    9_
$a OBJECTIVE: The World Apheresis Association (WAA) register contains data from more than 89 000 apheresis procedures in more than 12,000 patients. The aim of this study was to evaluate functional health and quality of life (QoL) in patients during apheresis treatment. MATERIAL AND METHODS: Estimates of health condition (HC) were made in 40,445 and of QoL in 22112 apheresis procedures. This study focused on a 10-step graded evaluation of HC (scale from: 'bedridden, unable to eat' to a level of 'athletic competition') and self-assessment of QoL (scale from: worst ever '0' to best ever '10'). Data were compared in relation to various apheresis procedures and if the patient underwent the first or subsequent apheresis procedure. RESULTS: Of the patients treated with plasma exchange (PEX) with centrifugation technique (n = 15787) 10% were 'bedridden, unable to come out of bed' while for patients treated with plasma filtration technique (n = 1018) the percentage was 27%. During the first procedure these figures were 16% and 30%, respectively. Self-estimates of QoL were graded 'zero' or '1' in 1.6% of patients during the first apheresis procedure; At the first contact patients undergoing PEX graded like this in 4.3%. CONCLUSION: Many of the patients undergoing apheresis treatment have poor HC and QoL at the start of therapy. Of all therapeutic apheresis procedures patients undergoing PEX had the lowest score of QoL.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    12
$a výměna plazmy $7 D010951
650    12
$a kvalita života $7 D011788
650    12
$a registrace $7 D012042
655    _2
$a klinické zkoušky $7 D016430
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
700    1_
$a Newman, E $u Australia.
700    1_
$a Witt, V $u Austria.
700    1_
$a Deeren, D $u Belgium.
700    1_
$a Blaha, M $u Czech Republic.
700    1_
$a Lanska, M $u Czech Republic.
700    1_
$a Gasova, Z $u Czech Republic.
700    1_
$a Bhuiyan-Ludvikova, Z $u Czech Republic.
700    1_
$a Hrdlickova, R $u Czech Republic.
700    1_
$a Ramlow, W $u Germany.
700    1_
$a Prophet, H $u Germany.
700    1_
$a Liumbruno, G $u Italy.
700    1_
$a Griskevicius, A $u Lithuania.
700    1_
$a Audzijoniene, J $u Lithuania.
700    1_
$a Vrielink, H $u the Netherlands.
700    1_
$a Aandahl, A $u Norway.
700    1_
$a Sanchez, S Ortega $u Spain.
700    1_
$a Strineholm, V $u Umeå, Sweden.
700    1_
$a Berlin, G $u Umeå, Sweden.
700    1_
$a Mörtzell-Henriksson, M $u Umeå, Sweden.
700    1_
$a Stegmayr, B G $u Umeå, Sweden. Electronic address: bernd.stegmayr@medicin.umu.se.
700    1_
$a Eich, T $u Umeå, Sweden.
700    1_
$a Ilhan, O $u Turkey.
773    0_
$w MED00008583 $t Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis $x 1473-0502 $g Roč. 58, č. 5 (2019), s. 641-644
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31519525 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201214130744 $b ABA008
999    __
$a ok $b bmc $g 1595981 $s 1114338
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 58 $c 5 $d 641-644 $e 20190905 $i 1473-0502 $m Transfusion and apheresis science $n Transfus Apher Sci $x MED00008583
LZP    __
$a Pubmed-20201125

Find record

Citation metrics

Archiving options